BioCentury
ARTICLE | Clinical News

Colloral oral tolerance treatment: Began Phase II trial

June 6, 1994 7:00 AM UTC

AutoImmune Inc. (AIMM), Lexington, Mass. Product: Colloral oral tolerance treatment, consisting of liquid type II collagen to be mixed with juice Indication: Active rheumatoid arthritis Status: Bega...